Novartis P/B Ratio
NOVARTIND • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
2.48
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
2.48
Current Price
₹800.55
Book Value/Share
₹654.17
Exchange
BSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹785 Cr
Share Capital
₹12 Cr
Reserves & Surplus
₹773 Cr
Outstanding Shares
12,000,000
Book Value per Share
₹654.17
Valuation Signal
Signal
Fairly Valued
Historical Avg
1.25
Historical Range
1.13 - 1.48
Percentile
100.0%
Sector Context
Sector Average
-0.1
Sector Median
0.66
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Novartis
- Current PB is 99.0% above historical average
- Trading at premium to sector average PB of -0.1
View the current stock price of Novartis for more insights.
P/B Ratio Historical Trend for Novartis
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Novartis
Additional stock information and data for NOVARTIND
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.19 | ₹654.17 | ₹779.00 | ₹785 | Moderate |
| 2024 | 1.48 | ₹620.83 | ₹919.80 | ₹745 | Moderate |
| 2023 | 1.16 | ₹646.67 | ₹748.25 | ₹776 | Moderate |
| 2022 | 1.13 | ₹576.67 | ₹650.00 | ₹692 | Moderate |
| 2021 | 1.27 | ₹592.5 | ₹750.30 | ₹711 | Moderate |
Sector P/B Ratio Comparison
Comparing Novartis with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.97 | ₹4,391 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.27 | ₹57 | Low |